StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)

Close on Nov 17, 2026Market cap $7.07MP/E –Yield –

Exicure ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Exicure's ebitda for the twelve months ending Jun 30, 2026 was -$7.14M. For fiscal 2025 it was -$3.99M. The highest annual figure on record is -$668.00K in fiscal 2022.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.99M–
FY2024Dec 31, 2024-$12.20M–
FY2023Dec 31, 2023-$14.36M–
FY2022Dec 31, 2022-$668.00K–
FY2021Dec 31, 2021-$61.43M–
FY2020Dec 31, 2020-$24.67M–
FY2019Dec 31, 2019-$26.23M–
FY2018Dec 31, 2018-$21.46M–
FY2017Dec 31, 2017-$10.18M–
FY2016Dec 31, 2016-$15.98M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.01M–
Q1 FY2026Mar 31, 2026-$1.59M-153.3%
Q4 FY2025Dec 31, 2025-$2.23M–
Q3 FY2025Sep 30, 2025-$2.31M–
Q2 FY2025Jun 30, 2025-$2.44M–
Q1 FY2025Mar 31, 2025$2.98M–
Q4 FY2024Dec 31, 2024-$7.58M–
Q3 FY2024Sep 30, 2024-$2.57M–
Q2 FY2024Jun 30, 2024-$1.23M–
Q1 FY2024Mar 31, 2024-$829.00K–
Q4 FY2023Dec 31, 2023-$1.49M-107.9%
Q3 FY2023Sep 30, 2023-$3.17M–
Q2 FY2023Jun 30, 2023-$5.41M–
Q1 FY2023Mar 31, 2023-$4.29M–
Q4 FY2022Dec 31, 2022$18.88M–
Q3 FY2022Sep 30, 2022-$4.92M–
Q2 FY2022Jun 30, 2022-$7.19M–
Q1 FY2022Mar 31, 2022-$7.44M–
Q4 FY2021Dec 31, 2021-$13.16M–
Q3 FY2021Sep 30, 2021-$22.80M–
Q2 FY2021Jun 30, 2021-$13.58M–
Q1 FY2021Mar 31, 2021-$11.89M-1844.0%
Q4 FY2020Dec 31, 2020-$12.19M–
Q3 FY2020Sep 30, 2020-$8.96M–
Q2 FY2020Jun 30, 2020-$4.20M–
Q1 FY2020Mar 31, 2020$682.00K–
Q4 FY2019Dec 31, 2019-$9.98M–
Q3 FY2019Sep 30, 2019-$5.86M–
Q2 FY2019Jun 30, 2019-$4.90M–
Q1 FY2019Mar 31, 2019-$5.49M–
Q4 FY2018Dec 31, 2018-$4.78M–
Q3 FY2018Sep 30, 2018-$5.77M–
Q2 FY2018Jun 30, 2018-$5.71M–
Q1 FY2018Mar 31, 2018-$5.20M–
Q4 FY2017Dec 31, 2017-$3.24M–
Q4 FY2016Dec 31, 2016-$5.40M–
Q3 FY2016Sep 30, 2016-$3.22M–

More Exicure figures

See a number that looks wrong?